(Q38969791)

English

The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Baoying Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Yicheng Xiong

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Lixian Wei

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Dawei Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Gang Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Di Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Tianxin Xu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Fengbo Zhao

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Mingyan Zhu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Chunhua Wan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

396

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

175-185

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25081333%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Hepatocellular carcinoma: A global view.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Tumor suppressor and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Ebp1 isoforms distinctively regulate cell survival and differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

ErbB3 binding protein-1 (Ebp1) controls proliferation and myogenic differentiation of muscle stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Hepatocellular carcinoma: current management and perspectives for the future

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Targeted therapy of hepatocellular carcinoma: present and future.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Two E2F elements regulate the proliferating cell nuclear antigen promoter differently during leaf development

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2153-9

21 January 2018

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25081333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25081333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis and treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25081333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/25081333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25081333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38969791&oldid=2202396667"